Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Coronary Artery Disease: HELP
Articles by Donatella Corrado
Based on 9 articles published since 2010
(Why 9 articles?)

Between 2010 and 2020, Domenico Corrado wrote the following 9 articles about Coronary Artery Disease.
+ Citations + Abstracts
1 Guideline Italian cardiological guidelines for sports eligibility in athletes with heart disease: part 2. 2013

Biffi, Alessandro / Delise, Pietro / Zeppilli, Paolo / Giada, Franco / Pelliccia, Antonio / Penco, Maria / Casasco, Maurizio / Colonna, Pierluigi / D'Andrea, Antonello / D'Andrea, Luigi / Gazale, Giovanni / Inama, Giuseppe / Spataro, Antonio / Villella, Alessandro / Marino, Paolo / Pirelli, Salvatore / Romano, Vincenzo / Cristiano, Antonio / Bettini, Roberto / Thiene, Gaetano / Furlanello, Francesco / Corrado, Domenico / Anonymous70757. ·National Italian Olympic Committee, Institute of Sports Medicine and Science, Rome, Italy. a.biffi@libero.it ·J Cardiovasc Med (Hagerstown) · Pubmed #23625056.

ABSTRACT: In Italy the existence of a law on health protection of competitive sports since 1982 has favored the creation and the revision of these cardiological guidelines (called COCIS), which have reached their fourth edition (1989-2009). The present article is the second English version, which has summarized the larger version in Italian. The experience of the experts consulted in the course of these past 20 years has facilitated the application and the compatibility of issues related to clinical cardiology to the sports medicine field. Such prolonged experience has allowed the clinical cardiologist to acquire knowledge of the applied physiology of exercise and, on the other hand, has improved the ability of sports physicians in cardiological diagnostics. All this work has produced these guidelines related to the judgment of eligibility for competitive sports in the individual clinical situations and in the different cardiovascular abnormalities and/or heart disease. Numerous arguments are debated, such as interpretation of the athlete's ECG, the utility of a preparticipation screening, arrhythmias, congenital heart disease, cardiomyopathies, arterial hypertension, ischemic heart disease and other particular issues.

2 Review Sudden death in athletes. 2017

Corrado, Domenico / Zorzi, Alessandro. ·Department of Cardiac, Thoracic and Vascular Sciences, University of Padua, Italy. Electronic address: domenico.corrado@unipd.it. · Department of Cardiac, Thoracic and Vascular Sciences, University of Padua, Italy. ·Int J Cardiol · Pubmed #28318658.

ABSTRACT: Competitive sports activity is associated with an increased risk of sudden cardiovascular death (SCD) in adolescents and young adults with clinically silent cardiovascular disorders. While in middle-aged/senior athletes atherosclerotic coronary artery disease accounts for the vast majority of SCDs, in young athletes the spectrum of substrates is wider and includes inherited (cardiomyopathies) and congenital (anomalous origin of coronary arteries) structural heart diseases. Inherited ion channel diseases have been implicated in SCDs occurring with an apparently normal heart at autopsy. Screening including the ECG allows identification of athletes affected by heart muscle diseases at a pre-symptomatic stage and may lead to reduction of the risk of SCD during sports. The use of modern criteria for interpretation of the ECG in the athlete offers the potential to improve the screening accuracy by reducing the number of false positives. Screening with exercise testing middle aged/senior athletes engaged in leisure sports activity is likely to be effective in patients with significant coronary risk factors, while it is not useful in low-risk subgroups. The availability of automated external defibrillator on the athletic field provides a "back-up" preventive strategy for unpredictable arrhythmic cardiac arrest, mostly occurring in patients with coronary artery diseases.

3 Review Risk of sports: do we need a pre-participation screening for competitive and leisure athletes? 2011

Corrado, Domenico / Schmied, Christian / Basso, Cristina / Borjesson, Mats / Schiavon, Maurizio / Pelliccia, Antonio / Vanhees, Luc / Thiene, Gaetano. ·Department of Cardiac, Thoracic and Vascular Science, University of Padua Medical School, Via Giustiniani, 2-35121 Padova, Italy. domenico.corrado@unipd.it ·Eur Heart J · Pubmed #21278396.

ABSTRACT: Sudden cardiac arrest is most often the first clinical manifestation of an underlying cardiovascular disease and usually occurs in previously asymptomatic athletes. The risk benefit ratio of physical exercise differs between young competitive athletes and middle-age/senior individuals engaged in leisure-time sports activity. Competitive sports are associated with an increase in the risk of sudden cardiovascular death (SCD) in susceptible adolescents and young adults with underlying cardiovascular disorders. In middle-age/older individuals, physical activity can be regarded as a 'two-edged sword': vigorous exertion increases the incidence of acute coronary events in those who did not exercise regularly, whereas habitual physical activity reduces the overall risk of myocardial infarction and SCD. Although cardiovascular pre-participation evaluation offers the potential to identify athletes with life-threatening cardiovascular abnormalities before onset of symptoms and may reduce their risk of SCD, there is a significant debate among cardiologists about efficacy, impact of false-positive results and cost-effectiveness of routine screening. This review presents an appraisal of the available data and criticisms concerning screening programmes aimed to prevent SCD of either young competitive athletes or older individuals engaged in leisure-time sports activity.

4 Clinical Trial "Full-plastic jacket" with everolimus-eluting Absorb bioresorbable vascular scaffolds: Clinical outcomes in the multicenter prospective RAI registry (ClinicalTrials.gov Identifier: NCT02298413). 2018

Tarantini, Giuseppe / Masiero, Giulia / Fovino, Luca Nai / Mojoli, Marco / Varricchio, Attilio / Loi, Bruno / Gistri, Roberto / Misuraca, Leonardo / Gabrielli, Gabriele / Cortese, Bernardo / Pisano, Francesco / Moretti, Luciano / Tumminello, Gabriele / Olivari, Zoran / Mazzarotto, Pietro / Colombo, Alessandro / Calabrò, Paolo / Nicolino, Annamaria / Tellaroli, Paola / Corrado, Donatella / Durante, Alessandro / Steffenino, Giuseppe / Anonymous1050951. ·Department of Cardiac, Thoracic and Vascular Sciences, University of Padua Medical School, Padua, Italy. Electronic address: giuseppe.tarantini.1@unipd.it. · Department of Cardiac, Thoracic and Vascular Sciences, University of Padua Medical School, Padua, Italy. · Interventional Cardiology, A.O. Monaldi, Naples, Italy. · Cardiology Division, A.O. Brotzu, Cagliari, Italy. · Interventional Cardiology, S. Andrea Hospital, La Spezia, Italy. · U.O. Cardiologia-Emodinamica, Ospedale della Misericordia, Grosseto, Italy. · Interventional Cardiology Unit, Azienda Ospedali Riuniti, Ancona, Italy. · Interventional Cardiology, A.O. Fatebenefratelli, Milan, Italy. · Interventional Cardiology, Parini Regional Hospital, Aosta, Italy. · Cardiology Division, Mazzoni Hospital, Ascoli Piceno, Italy. · Cardinal Massaia Hospital, Asti, Italy. · Cardiology Division, Ca' Foncello Hospital, Treviso, Italy. · Interventional Cardiology, Ospedale Maggiore, Lodi, Italy. · Interventional Cardiology Unit, Luigi Sacco Hospital, Milano, Italy. · Division of Cardiology, Department of Cardio-Thoracic Sciences, Second University of Naples, Naples, Italy. · Interventional Cardiology Unit, Santa Corona General Ospital, Pietra Ligure, Italy. · Biostatistics, Epidemiology and Public Health Unit of Department of Cardiac, Thoracic and Vascular Sciences, University of Padua Medical School, Padua, Italy. · "Mario Negri" Research Institute, Milano, Italy. · Cardiology Division, Valduce Hospital, Como, Italy. · USD Emodinamica, A.S.O. S.Croce e Carle, Cuneo, Italy. ·Int J Cardiol · Pubmed #29887475.

ABSTRACT: OBJECTIVES: The objective of this study was to investigate mid-term clinical outcomes of patients treated with 'full-plastic jacket' (FPJ) everolimus-eluting Absorb bioresorbable vascular scaffold (BRS) implantation. BACKGROUND: FPJ with BRS may represent an interesting option for patient with diffuse coronary artery disease (CAD), but data on the clinical impact of FPJ using the Absorb BRS are scant. METHODS: FPJ was defined as the implantation of >56 mm of overlapping BRS in at least one vessel. We compared outcomes of patients receiving Absorb FPJ vs. non-FPJ within the multicenter prospective RAI Registry. RESULTS: Out of 1505 consecutive patients enrolled in the RAI registry, 1384 were eligible for this analysis. Of these, 143 (10.3%) were treated with BRS FPJ. At a median follow-up of 649 days, no differences were observed between FPJ and non-FPJ groups in terms of the device-oriented composite endpoint (DoCE) (5.6% vs. 4.4%, p = 0.675) or the patient-related composite endpoint (PoCE) (20.9% vs. 15.9%, p = 0.149). Patients receiving FPJ had higher rates of target vessel repeat revascularization (TVR) (11.2% vs. 6.3%, p = 0.042). In the FPJ group, there was no cardiac death and only one (very late) stent thrombosis (ST) (0.7%). CONCLUSIONS: Mid-term outcomes of a FPJ PCI strategy in the setting of diffuse CAD did not show a significant increase in composite device- and patient-related events, with rates of cardiac death and ST comparable to non-FPJ Absorb BRS implantation. However, these findings are hypothesis generating and requiring further validation.

5 Article International Expert Consensus Document on Takotsubo Syndrome (Part I): Clinical Characteristics, Diagnostic Criteria, and Pathophysiology. 2018

Ghadri, Jelena-Rima / Wittstein, Ilan Shor / Prasad, Abhiram / Sharkey, Scott / Dote, Keigo / Akashi, Yoshihiro John / Cammann, Victoria Lucia / Crea, Filippo / Galiuto, Leonarda / Desmet, Walter / Yoshida, Tetsuro / Manfredini, Roberto / Eitel, Ingo / Kosuge, Masami / Nef, Holger M / Deshmukh, Abhishek / Lerman, Amir / Bossone, Eduardo / Citro, Rodolfo / Ueyama, Takashi / Corrado, Domenico / Kurisu, Satoshi / Ruschitzka, Frank / Winchester, David / Lyon, Alexander R / Omerovic, Elmir / Bax, Jeroen J / Meimoun, Patrick / Tarantini, Guiseppe / Rihal, Charanjit / Y-Hassan, Shams / Migliore, Federico / Horowitz, John D / Shimokawa, Hiroaki / Lüscher, Thomas Felix / Templin, Christian. ·University Heart Center, Department of Cardiology, University Hospital Zurich, Zurich, Switzerland. · Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA. · Division of Cardiovascular Diseases Mayo Clinic, Rochester, MN, USA. · Cardiovascular Research Division, Minneapolis Heart Institute Foundation, Minneapolis, MN, USA. · Department of Cardiology, Hiroshima City Asa Hospital, Hiroshima, Japan. · Division of Cardiology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan. · Department of Cardiovascular Sciences, Catholic University of the Sacred Heart, Rome, Italy. · Department of Cardiovascular Medicine, University Hospitals Leuven, Leuven, Belgium. · Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · Department of Cardiovascular Medicine, Onga Nakama Medical Association Onga Hospital, Fukuoka, Japan. · Clinica Medica, Department of Medical Sciences, University of Ferrara, Ferrara, Italy. · University Heart Center Luebeck, Medical Clinic II, Department of Cardiology, Angiology and Intensive Care Medicine, University of Luebeck, Luebeck, Germany. · Division of Cardiology, Yokohama City University Medical Center, Yokohama, Japan. · Department of Cardiology, University Hospital Giessen, Giessen, Germany. · Heart Department, University Hospital "San Giovanni di Dio e Ruggi d'Aragona", Salerno, Italy. · Department of Anatomy and Cell Biology, Wakayama Medical University School of Medicine, Wakayama, Japan. · Department of Cardiac, Thoracic, and Vascular Sciences, University of Padua Medical School, Padova, Italy. · Department of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan. · Division of Cardiovascular Disease, Department of Medicine, University of Florida, Gainesville, FL, USA. · NIHR Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London, UK. · National Heart and Lung Institute, Imperial College, London, UK. · Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden. · Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden. · Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands. · Department of Cardiology and Intensive Care, Centre Hospitalier de Compiegne, Compiegne, France. · Department of Cardiology, Karolinska University Hospital, Huddinge, Stockholm, Sweden. · Department of Cardiology, Basil Hetzel Institute, Queen Elizabeth Hospital, University of Adelaide, Adelaide, Australia. · Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan. · Center for Molecular Cardiology, Schlieren Campus, University of Zurich, Zurich, Switzerland. · Department of Cardiology, Royal Brompton & Harefield Hospital and Imperial College, London, UK. ·Eur Heart J · Pubmed #29850871.

ABSTRACT: Takotsubo syndrome (TTS) is a poorly recognized heart disease that was initially regarded as a benign condition. Recently, it has been shown that TTS may be associated with severe clinical complications including death and that its prevalence is probably underestimated. Since current guidelines on TTS are lacking, it appears timely and important to provide an expert consensus statement on TTS. The clinical expert consensus document part I summarizes the current state of knowledge on clinical presentation and characteristics of TTS and agrees on controversies surrounding TTS such as nomenclature, different TTS types, role of coronary artery disease, and etiology. This consensus also proposes new diagnostic criteria based on current knowledge to improve diagnostic accuracy.

6 Article Diagnostic value and prognostic implications of early cardiac magnetic resonance in survivors of out-of-hospital cardiac arrest. 2018

Zorzi, Alessandro / Susana, Angela / De Lazzari, Manuel / Migliore, Federico / Vescovo, Giovanni / Scarpa, Daniele / Baritussio, Anna / Tarantini, Giuseppe / Cacciavillani, Luisa / Giorgi, Benedetta / Basso, Cristina / Iliceto, Sabino / Bucciarelli Ducci, Chiara / Corrado, Domenico / Perazzolo Marra, Martina. ·Division of Cardiology, Department of Cardiac, Thoracic and Vascular Sciences, University of Padova, Padova, Italy. · Division of Cardiology, Department of Cardiac, Thoracic and Vascular Sciences, University of Padova, Padova, Italy; Bristol NIHR Cardiovascular Biomedical Research Unit, Bristol Heart Institute, University of Bristol, Bristol, United Kingdom. · Division of Radiology, Department of Medicine, Az. Ospedaliera di Padova, Padova, Italy. · Bristol NIHR Cardiovascular Biomedical Research Unit, Bristol Heart Institute, University of Bristol, Bristol, United Kingdom. · Division of Cardiology, Department of Cardiac, Thoracic and Vascular Sciences, University of Padova, Padova, Italy. Electronic address: domenico.corrado@unipd.it. ·Heart Rhythm · Pubmed #29550522.

ABSTRACT: BACKGROUND: In patients who survived out-of-hospital cardiac arrest (OHCA), it is crucial to establish the underlying cause and its potential reversibility. OBJECTIVE: The purpose of this study was to assess the incremental diagnostic and prognostic role of early cardiac magnetic resonance (CMR) in survivors of OHCA. METHODS: Among 139 consecutive OHCA patients, the study enrolled 44 patients (median age 43 years; 84% male) who underwent coronary angiography and CMR ≤7 days after admission. The CMR protocol included T2-weighted sequences for myocardial edema and late gadolinium enhancement (LGE) sequences for myocardial fibrosis. RESULTS: Coronary angiography identified obstructive coronary artery disease in 18 of 44 patients in whom CMR confirmed the diagnosis of ischemic heart disease by demonstrating subendocardial or transmural LGE. The presence of myocardial edema allowed differentiation between acute myocardial ischemia (n = 12) and postinfarction myocardial scar (n = 6). Among the remaining 26 patients without obstructive coronary artery disease, CMR in 19 (73%) showed dilated cardiomyopathy in 5, myocarditis in 4, mitral valve prolapse associated with LGE in 3, ischemic scar in 2, idiopathic nonischemic scar in 2, arrhythmogenic cardiomyopathy in 1, hypertrophic cardiomyopathy in 1, and takotsubo cardiomyopathy in 1. In this subgroup of 26 patients, 6 (23%) had myocardial edema. During mean follow-up of 36 ± 17 months, all 18 patients with myocardial edema had an uneventful outcome, whereas 9 of 26 (35%) without myocardial edema experienced sudden arrhythmic death (n = 1), appropriate defibrillator interventions (n = 5), and nonarrhythmic death (n = 3; P = .006). CONCLUSION: In survivors of OHCA, early CMR with a comprehensive tissue characterization protocol provided additional diagnostic and prognostic value. The identification of myocardial edema was associated with a favorable long-term outcome.

7 Article Thirty-Day Outcomes After Unrestricted Implantation of Bioresorbable Vascular Scaffold (from the Prospective RAI Registry). 2017

Cortese, Bernardo / Ielasi, Alfonso / Moscarella, Elisabetta / Loi, Bruno / Tarantini, Giuseppe / Pisano, Francesco / Durante, Alessandro / Pasquetto, Giampaolo / Colombo, Alessandro / Tumminello, Gabriele / Moretti, Luciano / Calabrò, Paolo / Mazzarotto, Pietro / Varricchio, Attilio / Tespili, Maurizio / Latini, Roberto A / Defilippi, Gianfranco / Corrado, Donatella / Steffenino, Giuseppe / Anonymous1980904. ·Division of Cardiology, ASST Fatebenefratelli-Sacco, "Fatebenefratelli" Hospital, Milan, Italy; Fondazione Monasterio-Centro Nazionale delle Ricerche-Regione Toscana, Massa, Italy. Electronic address: bcortese@gmail.com. · Division of Cardiology, ASST Bergamo Est, "Bolognini" Hospital, Seriate (BG), Italy. · Department of Cardio-Thoracic Science, Presidio Ospedaliero "Monaldi", Azienda Ospedaliera Dei Colli, Napoli, Italy. · Department of Cardiovascular Sciences, "Brotzu" Hospital, Cagliari, Italy. · Department of Cardiac, Thoracic, and Vascular Sciences, University Hospital of Padua, Padua, Italy. · Division of Cardiology, "Parini" Regional Hospital, Aosta, Italy. · Division of Cardiology, "Valduce" Hospital, Como, Italy. · Division of Cardiology, "Riuniti Hospital Padova Sud", Monselice (PD), Italy. · Division of Cardiology, ASST Fatebenefratelli-Sacco, "Sacco" Hospital, Milan, Italy. · Division of Cardiology, "Cardinal Massaia" Hospital, Asti, Italy. · Division of Cardiology, "Mazzoni" Hospital, Ascoli Piceno, Italy. · Division of Cardiology, Second University of Naples, "Monaldi" Hospital, Naples, Italy. · Division of Cardiology, Azienda Socio-Sanitaria Territoriale di Lodi, Lodi, Italy. · Division of Cardiology, ASST Fatebenefratelli-Sacco, "Fatebenefratelli" Hospital, Milan, Italy. · "Istituto di Ricerche Farmacologiche Mario Negri", Milan, Italy. · Interventional Cardiology Unit, "Santa Croce e Carle" Hospital, Cuneo, Italy. ·Am J Cardiol · Pubmed #28438304.

ABSTRACT: The Absorb biovascular scaffold (BVS) is a bioresorbable, everolimus-eluting scaffold whose data on real-world patients with complex lesions are limited. Short-term follow-up from recent studies point to a higher rate of 30-day thrombosis than observed with drug-eluting stents. We aimed to understand the short-term safety and efficacy of BVS. Registro Absorb Italiano (RAI, ClinicalTrials.gov:NCT02298413) is an Italian, prospective, multicenter registry not funded, whose aim is to investigate BVS performance through a 5-year follow-up of all consecutive patients who have undergone successful implantation of ≥1 BVS in different clinical/lesion subsets. Co-primary end points were target lesion revascularization and definite/probable thrombosis. Secondary end point was the occurrence of device-oriented cardiac events. The registry involved 23 centers, with patient enrollment from October 2012 to December 2015. We here report the 30-day outcomes of the whole population of the registry. We enrolled 1,505 consecutive patients, of which 82% were men and 22.4% diabetic. At presentation, 59.6% of the patients had an acute coronary syndrome, including 21% ST-elevation myocardial infarction. All lesions were pre-dilated and in 96.8% of the cases BVS was post-dilated. At 30 days, the co-primary study end point target lesion revascularization occurred in 0.6% of patients and definite/probable BVS thrombosis in 0.8%. There were 2 cases of cardiac and overall death (0.13%). Device-oriented cardiac events occurred in 1% of the patients. In conclusion, our data of consecutive patients suggest that current use of BVS in a wide spectrum of coronary narrowings and clinical settings is associated with good outcome at 30 days.

8 Article Registro Absorb Italiano (BVS-RAI): an investigators-owned and -directed, open, prospective registry of consecutive patients treated with the Absorb™ BVS: study design. 2015

Cortese, Bernardo / Ielasi, Alfonso / Varricchio, Attilio / Tarantini, Giuseppe / LaVecchia, Luigi / Pisano, Francesco / Facchin, Michela / Gistri, Roberto / D'Urbano, Maurizio / Lucci, Valerio / Loi, Bruno / Tumminello, Gabriele / Colombo, Alessandro / Limbruno, Ugo / Nicolino, Annamaria / Calzolari, Diego / Tognoni, Gianni / Defilippi, Gianfranco / Buccheri, Dario / Tespili, Maurizio / Corrado, Donatella / Steffenino, Giuseppe / Anonymous1140834. ·Azienda Ospedaliera Fatebenefratelli e Oftalmico, Milano. Electronic address: bcortese@gmail.com. · Azienda Ospedaliera Bolognini, Seriate (BG). · Ospedale Monaldi, Napoli. · Azienda Ospedaliera Universitaria, Padova. · Azienda Ospedaliera San Bortolo, Vicenza. · Ospedale Regionale, Aosta. · Ospedale di Este (PD). · Ospedale S.Andrea, La Spezia. · Ospedale di Magenta (MI). · Ospedale di Avezzano (AQ). · Azienda Ospedaliera Brotzu, Cagliari. · Ospedale Cardinal Massaia, Asti. · Ospedale Sacco, Milano. · Ospedale della Misericordia, Grosseto. · Ospedale Santa Corona, Pietra Ligure (SV). · Azienda Ospedaliera Ca Foncello, Treviso. · Centro di Ricerche Farmacologiche e Biomediche "Mario Negri", Milano. · Azienda Ospedaliera Fatebenefratelli e Oftalmico, Milano. · Azienda Sanitaria Ospedaliera Santa Croce e Carle, Cuneo. ·Cardiovasc Revasc Med · Pubmed #26100975.

ABSTRACT: BACKGROUND: The Absorb™ BVS is a bioresorbable, everolimus-eluting scaffold approved and marketed for coronary use. Published data on long-term results after treatment are limited to a small number of patients, most of them with elective PCI of simple lesions. The importance of scaffold resorption is variably appreciated among cardiologists, and indications for use from health technology assessment bodies or guidelines are missing. Instruments are needed to collect, share and assess the experience being accumulated with this new device in several centres. METHODS/DESIGN: The BVS-RAI Registry is a spontaneous initiative of a group of Italian interventional cardiologists in cooperation with Centro di Ricerche Farmacologiche e Biomediche "Mario Negri" Institute, and is not recipient of funding or benefits originating from the BVS manufacturer. It is a prospective registry with 5-year follow-up of all consecutive patients who have undergone successful implantation of 1 or more coronary BVS following the indications, techniques and protocols used in each of the participating institutions. Outcome measures are BVS target lesion failure within one year and device-oriented major adverse cardiac events within 5years. The registry started in October 2012 and will extend enrolment throughout 2015, with the aim to include about 1000 patients. ClinicalTrials.gov identifier is CT02298413. CONCLUSIONS: The BVS-RAI Registry will contribute observational knowledge on the long-term safety and efficacy of the Absorb™ BVS as used in a number of Italian interventional centres in a broad spectrum of settings. Unrewarded and undirected consecutive patient enrolments are key-features of this observation, which is therefore likely to reflect common clinical practice in those centres.

9 Article Comparison of United States and Italian experiences with sudden cardiac deaths in young competitive athletes: are the athletic populations comparable? 2010

Corrado, Domenico / Basso, Cristina / Thiene, Gaetano. · ·Am J Cardiol · Pubmed #20102961.

ABSTRACT: -- No abstract --